Maestro Raises $3M Series A to Expand in Esports and Pioneer Engagement and Analytics Platform for Enterprise Live Streamers
Maestro (http://maestro.io), the engagement and analytics platform for enterprise live streamers, announced the close of a $3 million Series A financing. The round is led by Hersh Interactive Group with additional investors Rubicon Venture Capital (investor in Unikrn) and the Stanford-StartX Fund. This brings the total capital raised by the company to $5.8M when added to the previous $2.8M Seed funding which included 500 Startups (led by former Hulu exec, Andrei Marinescu), Scrum Ventures, Three Six Zero Group, and Larry and Drew Marcus, partners at Walden Venture Capital.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170907006262/en/
Maestro: Enabling Enterprise Live Streamers to Own, Engage, and Monetize their Audiences (www.maestro.io) (Graphic: Business Wire)
Video consumption is expected to continue its staggering growth and live streaming is one of the fastest growing sub categories, but the traditional tools on which the industry relies, such as Nielsen, are no longer keeping up with today’s demands. For enterprises, viewership is no longer solely about eyeballs; instead, it is much more about engagement and identifying the levers that drive KPIs.
The Maestro platform enables a new category of live experiences that facilitates two-way interactions between streamers and their audiences. The days where a stream experience is simply a video with a chat on the side are coming to an end. In this new live stream era, “maestros” engage audiences to take action during key moments. Polls, commerce, contests, share prompts, and giveaways are triggered in real-time, which significantly increase watch time while capturing a robust set of user data to understand audiences and data-drive decisions. Maestro’s audience database system represents Nielsen for the cord cutter generation, trading estimates for actual user-level data augmented by engagement to provide a deep understanding of audiences. This first-of-its-kind solution creates experiences fans love while solving one of live streaming’s main challenges and in effect transforms the medium into a meaningful tool for business growth.
The company has focused on the rapidly growing esports and gaming market of 2.6B gamers worldwide. “Especially as the audience for watching eSports grows, live streaming will take a bigger share of the media marketplace … and that means more money for whoever can best engage with the new audience,” according to TechCrunch on Maestro’s funding announcement. Many industry titans have already leveraged Maestro on their own custom-branded destinations: Sony PlayStation, Microsoft, Pokemon, Warner Bros. Games, Electronic Arts, Capcom, Wargaming, ESL, Dreamhack, ELEAGUE, and more. “Maestro’s rapid penetration within esports supports our thesis that publishers, leagues, and teams will increasingly seek ways to connect with their audiences through branded experiences they control. The product’s strategic design provides a framework for continued innovation and value creation to propel the industry forward as it evolves,” said Randy Chappel, Managing Director of HIG.
Esports and gaming aren’t the only verticals embracing the cord cutting trend; enterprises across industries are actively seeking opportunities to create unique, authentic experiences for their audiences. The content analytics market is expected to grow to $4.37B by 2021, demonstrating the shift to data-driven content strategies. Maestro works with any video player, making it easy to layer into existing video distribution with major platforms. The company plans to use proceeds to continue expansion into additional categories of content, with customers such as Adobe, The GRAMMY Awards, and Coachella proving demand for Maestro’s solution.
“As sophistication around streaming becomes the norm, the new metrics revolve around quality of interaction, retention, and attribution to the bottom line. We’re excited to enable businesses around the world to create robust, long-term live streaming strategies through their own destinations,” said Ari Evans, founder and Chief Executive Officer.
Maestro provides a white-label platform for enterprise live streamers to own, engage, and monetize their audiences. The software focuses on engagement tools that drive actions at key moments while capturing user data to be used in analytics and marketing campaigns. Customers include Microsoft, PlayStation, E3, ESL, Capcom, WB Games, ELEAGUE, Dreamhack, Blizzard Entertainment, Coachella, The GRAMMY Awards and more.
Maestro has participated in startup accelerators 500 Startups’ Dojo and Stanford University’s StartX. The company won the 2017 Manatt Digital eSports Startup Launchpad and was recognized as a finalist in a variety of competitions including 2017 Digital Entertainment World, 2017 Midemlab, 2016 SXSW Accelerator, and 2016 NFL 1st & Future (hosted by TechCrunch and Stanford). To learn more, visit www.maestro.io.
Tiffany Au, Director of Communications
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31 | Pressemelding
Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00 | Pressemelding
AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20 | Pressemelding
AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11 | Pressemelding
The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other
Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20 | Pressemelding
Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to
Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31 | Pressemelding
Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom